Related Articles
miR‑101‑3p negatively regulates inflammation in systemic lupus erythematosus via MAPK1 targeting and inhibition of the NF‑κB pathway
Association of calreticulin expression with disease activity and organ damage in systemic lupus erythematosus patients
Increased interleukin‑9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus
Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis
Association of toll‑like receptor 9 expression with prognosis of systemic lupus erythematosus